Other News To Note
Tuesday, May 3, 2011
Concert Pharmaceuticals Inc., of Lexington, Mass., presented preclinical data showing C-10068 has activity in models of epilepsy, neuroprotection and neuropathic pain. The drug showed anti-convulsant activity in models of both grand mal and partial seizures, and it inhibited hippocampal neurotoxicity and demonstrated neuroprotective effects. The data were presented at the Antiepileptic Drug Trials XI Conference.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.